OrthoPediatrics Corp.

OrthoPediatrics Corp.

NNASDAQ:KIDS
31.76
USD
-0.46
(-1.43%)
-1.42EPS
581.58MMarket Cap
Mar 10Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
3.18
4.13
4.96
9.47
4.58
4.96
3.94
5.09
5.91
6.56
8.87
10.07
11.07
Basic EPS, GAAP
-1.28
-1.69
-1.66
-4.88
-0.96
-0.94
-1.82
-0.84
0.06
-0.92
-1.64
-1.69
-1.42
Free Cash Flow per Basic Share
-1.78
-0.42
-0.78
-2.86
-1.67
-2.04
-1.65
-1.51
-1.54
-2.03
-1.79
-0.68
0.13
Dividend per Share
- -
- -
- -
1.24
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-3.54
-4.49
-5.42
3.76
5.62
8.51
12
11.45
16.55
16.13
14.64
13.81
12.99
Tangible Book Value per Share
-3.61
-4.57
-5.53
3.58
5.47
6.55
5.11
4.23
9.26
8.93
7.41
6.36
5.62
Basic Weighted Avg Shares
7
8
8
5
13
15
18
19
21
23
23
23
24
Sales/Revenue/Turnover
24
31
37
46
58
73
71
98
122
149
205
236
264
Operating Margin (%)
-30.16
-21.26
-16.43
-14.19
-16.6
-12.51
-28.72
-18.23
-17.82
-17.32
-14.42
-12.27
-8.15
Depreciation Expense
2
2
2
2
3
5
8
11
13
17
19
21
23
Net Income, GAAP
-10
-8
-7
-9
-12
-14
-33
-16
1
-21
-38
-40
-34
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-40.32
-25.45
-17.62
-19.58
-20.89
-18.93
-46.35
-16.58
1.03
-14.1
-18.47
-16.78
-12.83
Working Capital
24
16
14
60
88
114
123
104
196
185
203
210
198
LT Debt
13
13
17
25
21
26
1
1
1
10
73
100
98
Total Equity
18
11
6
47
82
142
235
225
379
377
355
347
339
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
-18.61
-12.25
-17.47
-7.07
0.42
-5.55
-10.34
-11.31
-9.84

Capital Structure

USD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
- -
- -
- -
LT Borrowings
100
99
98
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
26
26
26
Market Capitalization
406
500
582

Working Capital

USD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
246
253
253
Cash, Cash Equivalents & STI
49
46
44
Accounts Receivable, Net
54
61
60
Inventories
134
138
142
Total Current Liabilities
47
53
56
Payables & Accruals
22
23
26
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
91.19%
11.07%
-2.25%
Free Cash Flow
29.58%
-4%
-61.36%
Net Income, GAAP
-163.25%
-368.09%
4.83%
Sales/Revenue/Turnover
23.02%
27.48%
15.45%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
45
53
55
53
205
2025
52
61
61
62
236
2026
59
71
73
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.34
-0.26
-0.34
-0.69
-1.64
2025
-0.46
-0.3
-0.5
-0.43
-1.69
2026
-0.45
-0.3
-0.25
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
David R. Bailey
Full Time Employees
602
Sector
Health technology
Industry
Medical specialties
Address
2850 Frontier Drive Warsaw IN United States 46582
IPO Date
Oct 12, 2017
Business
OrthoPediatrics Corp. is a medical technology enterprise dedicated to the design, development, and commercialization of specialized implants, instruments, and bracing solutions tailored for children confronting orthopedic conditions across the United States and internationally. The company provides a broad range of offerings encompassing trauma and deformity correction, comprehensive scoliosis management including spinal growth guidance systems, and sports medicine procedures. Key product lines include various nailing platforms such as PediNail and PediFlex nail, plate systems like PediPlates, cannulated screws, and advanced solutions such as RESPONSE Spine systems, ApiFix Mid-C System, and the recently introduced VerteGlide Spinal Growth Guidance System. Additionally, its OrthoPediatrics Specialty Bracing (OPSB) division expands its non-surgical solutions. Serving the distinct pediatric orthopedic market, the company partners with pediatric orthopedic surgeons and caregivers. Founded in 2006, OrthoPediatrics Corp. maintains its headquarters in Warsaw, Indiana.

Company News

  • OrthoPediatrics to Participate in Upcoming Conferences

  • All You Need to Know About OrthoPediatrics (KIDS) Rating Upgrade to Buy

  • OrthoPediatrics Corp. (KIDS) Q3 2026 Earnings Call Transcript

  • OrthoPediatrics: 3 Key Takeaways for Long-Term Investors

  • OrthoPediatrics Q3 Earnings Call Highlights

  • OrthoPediatrics (KIDS) Reports Q3 Loss, Tops Revenue Estimates

  • OrthoPediatrics Corp. Reports Third Quarter 2026 Financial Results and Increases 2026 Financial Guidance

  • OrthoPediatrics Announces FDA 510(k) Clearance of PNP | Femur Retrograde Nail System and Completes First Implantations

  • ICE's TTF Options Reach Record Open Interest as Customers Hedge Natural Gas Price Risk

  • POTTERY BARN KIDS AND POTTERY BARN TEEN UNVEIL TEN HOLIDAY COLLABORATIONS FEATURING ICONIC CHARACTERS, BRANDS AND DESIGNERS

  • Head-To-Head Survey: Trinity Biotech (NASDAQ:TRIB) vs. OrthoPediatrics (NASDAQ:KIDS)

  • OrthoPediatrics Corp. to Report Third Quarter Financial Results on October 27, 2026

  • SOUR PATCH KIDS Declares Halloween is Mischief Season with 13 Days of Mischief

  • Critical Survey: OrthoPediatrics (NASDAQ:KIDS) vs. SS Innovations International (NASDAQ:SSII)

  • OrthoPediatrics Expands Its Lower Extremity Bracing Portfolio with the Launch of OPSB® Knee 'TractorFIX

  • ICE Launches New VLCC Tanker and Container Freight Contracts as Customers Hedge Freight Risk Across Global Trade Routes

  • OrthoPediatrics Sponsors the 10th Pediatric Orthopedic Surgical Techniques Course

  • OrthoPediatrics Surpasses 1,000 PNP Tibia Nail Implantations

  • OrthoPediatrics Corp (KIDS) Stock Down 6.0% -- Now Undervalued? GF Score: 84/100

  • ICE Launches Private Credit Reference Data Service